Q-Line Biotech IPO GMP today is Rs 109. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
SME IPO
QLINEBIOTECH
Q-Line Biotech IPO GMP, Subscription & Allotment Status Today
Q-Line Biotech is a SME IPO with a price band of Rs 326.00 to Rs 343.00 that listed on 29 May 2026 at a listing gain of +31.78%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹326.00 - ₹343.00
- Lot Size
- 400 Shares
- Bidding Closes
- 25 May 2026
- Listing Date
- 29 May 2026
Current GMP Status
₹109
+31.78% vs upper band
Est. Listing Gain
+31.78%
Last Trend
26 May 2026
Listing Price
₹452.00
Retail Entry
₹2,74,400
IPO Details
Complete IPO information
| Current GMP | ₹109 |
|---|---|
| Estimated Listing Gain | +31.78% |
| Price Band | ₹326.00 - ₹343.00 |
| Issue Price | Approx ₹343.00 Crores |
| Listing Price | ₹452.00 |
| Lot Size | 400 Shares |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | 50.82x |
| Listing Date | 29 May 2026 |
| Minimum Investment | ₹2,74,400 |
Head-to-head
Compare Q-Line Biotech IPO with similar IPOs
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Q-Line Biotech is priced at ₹343 per share. With a minimum lot size of 400 shares, a retail investor applying for one lot would need approximately ₹2,74,400 to participate in this SME issue.
The latest recorded Grey Market Premium for Q-Line Biotech stands at ₹109, implying an estimated listing gain of around 31.78% over the issue price if it holds until listing. This is down ₹24 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Q-Line Biotech's IPO was subscribed 50.82x overall, with a category-wise breakdown of Retail 47.12x, QIB 25.34x.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
21 May 2026
✓
Bidding Closes
25 May 2026
✓
Allotment
26 May 2026
✓
Listing
29 May 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 26 May 2026 | ₹101.00 | -₹24.00 | 29.45% |
| 25 May 2026 | ₹125.00 | +₹14.50 | 36.44% |
| 20 May 2026 | ₹110.50 | - | 32.22% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 800 | ₹2,74,400 |
| Retail Maximum | 2 Lot | 800 | ₹2,74,400 |
| S-HNI Minimum | 3 Lot | 1,200 | ₹4,11,600 |
| S-HNI Maximum | 7 Lot | 2,800 | ₹9,60,400 |
| B-HNI Minimum | 8 Lot | 3,200 | ₹10,97,600 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Q-Line Biotech IPO Details
| Particulars | Details |
|---|---|
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹326 to ₹343 Per Share |
| Issue Size | Approx ₹214 Crores, 62,53,200 Equity Shares |
| Fresh Issue | Approx ₹214 Crores, 62,53,200 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
Analysis
IPO Reservation
| Investor Category | Share Offered | Shares (%) |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 29,69,200 Shares | 50% |
| NII Shares Offered | 8,91,600 Shares | 15% |
| Retail Shares Offered | 20,79,200 Shares | 35% |
Analysis
Q-Line Biotech IPO Anchor Investors
| Particulars | Details |
|---|---|
| Anchor Bidding Date | 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| Lock-in Period End Date 50% Shares (30 Days) | 2026 |
| Lock-in Period End Date 50% Shares (90 Days) | 2026 |
Analysis
Q-Line Biotech IPO Dates
The Q-Line Biotech IPO date is May 21, and the close date is May 25. The Q-Line Biotech IPO allotment will be finalized on May 26, and the IPO listing on May 29.
| Event | Date |
|---|---|
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Basis of Allotment | May 26, 2026 |
| Refunds | May 27, 2026 |
| Credit to Demat Account | May 27, 2026 |
| IPO Listing Date | May 29, 2026 |
| IPO Bidding Cut-off Time | May 25, 2026 – 5 PM |
Analysis
Promoters and Holding Pattern
The promoters of the company are Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty and Abhay Agrawal.
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 1,70,74,999 | 96.77% |
| Promoter Holding Post Issue | 2,33,28,199 | -% |
Analysis
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
|---|---|
| To Meet Working Capital Requirements | ₹110.00 |
| Repayment of Certain Borrowing Availed by the Company, in Part or Full | ₹90.00 |
| General Corporate Purpose | ₹- |
Analysis
About Q-Line Biotech IPO
Since its incorporation in 2013, Q-Line Biotech has been involved in the healthcare and diagnostic industry. The firm is known for manufacturing and supplying In-Vitro Diagnostic (IVD) products, medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. The firm has been known to offer high-quality products and services at an affordable price range.
Q-Line Biotech has over 15 years of experience in the diagnostic industry and has served 150+ national and international clients. Moreover, the company also has 12 years of experience in developing and manufacturing various products. Its product range includes haematology, POC testing, clinical chemistry, molecular diagnostics, rapid tests, ELISA, and special diagnostics.
Analysis
Q-Line Biotech IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹184.81 | ₹154.97 | ₹32.10 | ₹251.58 |
| 2024 | ₹206.45 | ₹175.85 | ₹34.44 | ₹339.25 |
| 2025 | ₹322.58 | ₹261.43 | ₹28.13 | ₹455.49 |
| Dec 2025 | ₹236.50 | ₹186.96 | ₹38.69 | ₹561.34 |
Analysis
Q-Line Biotech IPO Valuation – FY2025
Check Q-Line Biotech IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
|---|---|
| ROE | 17.66% |
| ROCE | 23.74% |
| EBITDA Margin | 22.73% |
| PAT Margin | 8.97% |
| Debt to Equity Ratio | 0.87 |
| Earning Per Share (EPS) | ₹28.63 (Basic) |
| Price/Earning P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 23.74% |
| Net Asset Value (NAV) | ₹120.60 |
Analysis
Peer Group Comparison
There are no listed companies in India.
Analysis
IPO Lead Managers aka Merchant Bankers
- Hem Securities Ltd.
- Share India Capital Services Pvt. Ltd.
FAQ
Q-Line Biotech IPO FAQs
Q-Line Biotech IPO price band is Rs 326.00 to Rs 343.00. Check the latest issue price, lot size and GMP together before applying.
Q-Line Biotech IPO open date is 21 May 2026, close date is 25 May 2026, and listing date is 29 May 2026.
Q-Line Biotech IPO lot size is 400 shares. The minimum retail investment is Rs 2,74,400.
Q-Line Biotech is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Q-Line Biotech IPO subscription status currently shows Retail 47.12x, QIB 25.34x, Overall 50.82x.
Q-Line Biotech IPO issue size is TBA and the expected allotment date is 26 May 2026.
Community discussion
Comments
Share a useful question or insight about Q-Line Biotech.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
SME
R.K.Fashion Accessories
Price Band₹77.00 - ₹82.00
Current GMP₹0
Lot Size1,600 Shares
SME
Dove Soft
Price Band₹104.00 - ₹111.00
Current GMP₹0
Lot Size1,200 Shares
SME
Paramount Syntex
Price Band₹119.00 - ₹127.00
Current GMP₹0
Lot Size1,000 Shares
SME
Omara Ventures India
Price Band₹296.00 - ₹311.00
Current GMP₹0
Lot Size400 Shares
Loading comments...